Xerafy is set to highlight its cutting-edge smart RAIN RFID labeling solutions tailored for the pharmaceutical and healthcare sectors at the AIPIA Innovation Stage during CPHI South East Asia 2026. This event is scheduled from July 8 to 10 in Bangkok, Thailand, where the company will demonstrate how these technologies can enhance various aspects of pharmaceutical and medical device packaging.
The RFID labeling solutions from Xerafy aim to revolutionize the industry by improving packaging, traceability of medical devices, inventory management, and visibility across healthcare supply chains. Among the innovative products on display will be the XSKIN Gamma, designed for gamma-sterilized packaging, the MICRO Medical for identifying compact medical devices, and the Metal Skin Delta, which is suited for use with on-metal healthcare assets and metallized packaging.
As pharmaceutical supply chains grow more intricate, the integration of smart RAIN RFID labels facilitates item-level identification and real-time data capture throughout processes like manufacturing, sterilization, warehousing, and distribution. These advancements are crucial for enhancing product traceability, inventory precision, and regulatory compliance by effectively linking physical items with their digital counterparts.
Xerafy emphasizes that its RFID solutions are engineered for challenging environments where conventional barcode systems may fall short. This is particularly relevant in scenarios involving bulk handling, dense storage, and regulated healthcare applications. The company’s offerings include specialized RFID labels and tags that cater to a wide range of sectors, including healthcare, manufacturing, logistics, aerospace, oil and gas, and data centers.
The demonstration at CPHI South East Asia 2026 will showcase how the integration of connected packaging and RFID technology can lead to more streamlined and efficient pharmaceutical and medical device supply chains, highlighting the potential for these advancements to transform industry standards.
Legal Disclaimer: The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.